Annual Total Liabilities
$10.32 M
+$1.40 M+15.70%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual total liabilities is $10.32 million, with the most recent change of +$1.40 million (+15.70%) on December 31, 2023.
- During the last 3 years, VVOS annual total liabilities has risen by +$1.91 million (+22.70%).
- VVOS annual total liabilities is now -1.67% below its all-time high of $10.49 million, reached on December 31, 2019.
Performance
VVOS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$7.68 M
-$1.81 M-19.09%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly total liabilities is $7.68 million, with the most recent change of -$1.81 million (-19.09%) on September 30, 2024.
- Over the past year, VVOS quarterly total liabilities has dropped by -$2.64 million (-25.55%).
- VVOS quarterly total liabilities is now -34.02% below its all-time high of $11.64 million, reached on June 30, 2023.
Performance
VVOS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
VVOS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.7% | -25.6% |
| 3 y3 years | +22.7% | -10.2% |
| 5 y5 years | +205.6% | +0.9% |
VVOS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.6% | -34.0% | at low |
| 5 y | 5-year | -1.7% | +26.6% | -34.0% | +0.9% |
| alltime | all time | -1.7% | +205.6% | -34.0% | +0.9% |
Vivos Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.68 M(-19.1%) |
| Jun 2024 | - | $9.49 M(-15.4%) |
| Mar 2024 | - | $11.22 M(+8.8%) |
| Dec 2023 | $10.32 M(+15.7%) | $10.32 M(+0.5%) |
| Sep 2023 | - | $10.27 M(-11.8%) |
| Jun 2023 | - | $11.64 M(+15.2%) |
| Mar 2023 | - | $10.11 M(+13.3%) |
| Dec 2022 | $8.92 M | $8.92 M(+4.4%) |
| Sep 2022 | - | $8.54 M(-10.4%) |
| Jun 2022 | - | $9.54 M(+9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $8.70 M(+6.8%) |
| Dec 2021 | $8.15 M(-3.1%) | $8.15 M(-4.7%) |
| Sep 2021 | - | $8.55 M(-11.6%) |
| Jun 2021 | - | $9.67 M(+27.0%) |
| Mar 2021 | - | $7.61 M(-9.5%) |
| Dec 2020 | $8.41 M(-19.9%) | $8.41 M(-19.2%) |
| Sep 2020 | - | $10.41 M(+14.4%) |
| Jun 2020 | - | $9.10 M(-13.3%) |
| Dec 2019 | $10.49 M(+210.7%) | $10.49 M |
| Dec 2018 | $3.38 M | - |
FAQ
- What is Vivos Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Vivos Therapeutics?
- What is Vivos Therapeutics annual total liabilities year-on-year change?
- What is Vivos Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly total liabilities year-on-year change?
What is Vivos Therapeutics annual total liabilities?
The current annual total liabilities of VVOS is $10.32 M
What is the all time high annual total liabilities for Vivos Therapeutics?
Vivos Therapeutics all-time high annual total liabilities is $10.49 M
What is Vivos Therapeutics annual total liabilities year-on-year change?
Over the past year, VVOS annual total liabilities has changed by +$1.40 M (+15.70%)
What is Vivos Therapeutics quarterly total liabilities?
The current quarterly total liabilities of VVOS is $7.68 M
What is the all time high quarterly total liabilities for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly total liabilities is $11.64 M
What is Vivos Therapeutics quarterly total liabilities year-on-year change?
Over the past year, VVOS quarterly total liabilities has changed by -$2.64 M (-25.55%)